SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-012767
Filing Date
2022-12-19
Accepted
2022-12-19 18:56:35
Documents
1
Period of Report
2022-12-15

Document Format Files

Seq Description Document Type Size
1 form4-12192022_111223.html 4  
1 form4-12192022_111223.xml 4 3955
  Complete submission text file 0001415889-22-012767.txt   5435
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address
Atadja Peter (Reporting) CIK: 0001958563 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 221472442